Clinical Trials Browser

Phase 3 × OTHER × Decitabine × Clear all

NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Phase 3 Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

NCT06297772 2024-06-04

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06073730 2023-10-10

Viale-a

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Phase 3 Recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05382390 2022-05-19

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03257241 2021-10-01

PALG-AML1/2016

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04292769 2020-03-03

Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Phase 3 Unknown

Neoplasms

NCT04087967 2019-09-12

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04083911 2019-09-10

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03553537 2018-06-12

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Phase 3 Unknown

Lymphoma, T-Cell, Peripheral

NCT02985372 2016-12-07

Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute